Clinical Trial Update: Safety Study of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1 [Phase 2]

View source ↗

Summary

Phase 2 safety trial update for dosing Tier 1 of human chorionic gonadotropin (hCG) and epoetin alfa in traumatic brain injury; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)
• human chorionic gonadotropin (hCG) (human chorionic gonadotropin)

Snippet

Sponsor: University of Calgary | Conditions: Traumatic Brain Injury | Phase 2 | Status: UNKNOWN